利伐沙班治疗难治性肝素诱导的血小板减少症。
Rivaroxaban in treatment refractory heparin-induced thrombocytopenia.
作者信息
Casan Joshua Misha Lewis, Grigoriadis George, Chan Noel, Chunilal Sanjeev
机构信息
Department of Haematology, Monash Health, Clayton, Victoria, Australia.
出版信息
BMJ Case Rep. 2016 Aug 12;2016:bcr2016216110. doi: 10.1136/bcr-2016-216110.
Abstract
Following orthopaedic surgery, a 56-year-old woman developed heparin-induced thrombocytopenia (HIT), complicated by extensive proximal deep vein thrombosis. The patient did not respond to multiple conventional therapies; however, a prompt treatment response occurred after starting rivaroxaban at standard dosing. This case represents the first documentation of efficacy for rivaroxaban in the setting of treatment refractory HIT and strengthens the limited existing evidence for this agent in HIT.
摘要
一名56岁女性在接受骨科手术后发生肝素诱导的血小板减少症（HIT），并伴有广泛的近端深静脉血栓形成。该患者对多种传统疗法均无反应；然而，在开始使用标准剂量的利伐沙班后迅速出现治疗反应。该病例是利伐沙班在治疗难治性HIT中的疗效的首次记录，并加强了该药物在HIT中现有有限的证据。
相似文献
1
Rivaroxaban in treatment refractory heparin-induced thrombocytopenia.
BMJ Case Rep. 2016 Aug 12;2016:bcr2016216110. doi: 10.1136/bcr-2016-216110.
2
[Treatment of heparin-induced thrombocytopenia with rivaroxaban. Case report].
Rev Med Chil. 2017 Sep;145(9):1213-1217. doi: 10.4067/s0034-98872017000901213.
3
Heparin-induced Thrombocytopenia Presenting With Deep Venous Thrombosis and Pulmonary Embolism Successfully Treated With Rivaroxaban: Clinical Case Report and Review of Current Experiences.
J Cardiovasc Pharmacol. 2016 Nov;68(5):391-394. doi: 10.1097/FJC.0000000000000421.
4
Rivaroxaban for heparin-induced thrombocytopenia: adding to the evidence.
Ann Hematol. 2017 Mar;96(3):525-527. doi: 10.1007/s00277-016-2871-z. Epub 2016 Nov 7.
5
Rivaroxaban as an Alternative Agent for Heparin-Induced Thrombocytopenia.
J Clin Pharmacol. 2020 Oct;60(10):1362-1366. doi: 10.1002/jcph.1635. Epub 2020 Jun 10.
6
Can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism?
Anatol J Cardiol. 2017 Jul;18(1):77-79. doi: 10.14744/AnatolJCardiol.2017.7805.
7
Design of the rivaroxaban for heparin-induced thrombocytopenia study.
J Thromb Thrombolysis. 2014 Nov;38(4):485-92. doi: 10.1007/s11239-014-1064-7.
8
Rivaroxaban for treatment of suspected or confirmed heparin-induced thrombocytopenia study.
J Thromb Haemost. 2016 Jun;14(6):1206-10. doi: 10.1111/jth.13330. Epub 2016 May 10.
9
Rivaroxaban and apixaban for the treatment of suspected or confirmed heparin-induced thrombocytopenia.
J Clin Pharm Ther. 2022 Jan;47(1):112-118. doi: 10.1111/jcpt.13537. Epub 2021 Oct 26.
10
Rivaroxaban for treatment of heparin-induced thrombocytopenia after cardiac surgery: A case report.
J Thorac Cardiovasc Surg. 2015 Aug;150(2):e19-20. doi: 10.1016/j.jtcvs.2015.04.054. Epub 2015 May 8.
引用本文的文献
1
Autoimmune Heparin-Induced Thrombocytopenia.
J Clin Med. 2023 Nov 3;12(21):6921. doi: 10.3390/jcm12216921.
2
Rivaroxaban Treatment for Heparin-Induced Thrombocytopenia: A Case Report and a Review of the Current Experience.
Case Rep Hematol. 2020 Sep 3;2020:8885256. doi: 10.1155/2020/8885256. eCollection 2020.
3
Autoimmune Heparin-Induced Thrombocytopenia: Treatment Obstacles and Challenging Length of Stay.
Am J Case Rep. 2019 Mar 9;20:310-313. doi: 10.12659/AJCR.914575.
本文引用的文献
1
Rivaroxaban for treatment of suspected or confirmed heparin-induced thrombocytopenia study.
J Thromb Haemost. 2016 Jun;14(6):1206-10. doi: 10.1111/jth.13330. Epub 2016 May 10.
2
Rivaroxaban for treatment of heparin-induced thrombocytopenia after cardiac surgery: A case report.
J Thorac Cardiovasc Surg. 2015 Aug;150(2):e19-20. doi: 10.1016/j.jtcvs.2015.04.054. Epub 2015 May 8.
3
Rivaroxaban in the Treatment of Heparin-Induced Thrombocytopenia.
J Thromb Thrombolysis. 2015 Oct;40(3):392-4. doi: 10.1007/s11239-015-1208-4.
4
Rivaroxaban for arterial thrombosis related to heparin-induced thrombocytopenia.
Blood Coagul Fibrinolysis. 2015 Mar;26(2):205-6. doi: 10.1097/MBC.0000000000000205.
5
First experiences with the use of rivaroxaban in the treatment of heparin-induced thrombocytopenia.
Thromb Res. 2015 Jan;135(1):205-7. doi: 10.1016/j.thromres.2014.06.005. Epub 2014 Jun 14.
6
Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Chest. 2012 Feb;141(2 Suppl):e495S-e530S. doi: 10.1378/chest.11-2303.
7
Rivaroxaban--an oral, direct Factor Xa inhibitor--has potential for the management of patients with heparin-induced thrombocytopenia.
Br J Haematol. 2008 Oct;143(1):92-9. doi: 10.1111/j.1365-2141.2008.07300.x. Epub 2008 Jul 30.
8
Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia.
Thromb Haemost. 1992 Jul 6;68(1):95-6.
Zotero 插件